This association with the outcome of the patients support the recent confirmation of MMP-2 as one of the candidate cancer genes (CAN genes) by the number and nature of mutations and pathways in colorectal cancer (Sjöblom et al, 2006). This evidence concerns the gene MMP2 and colorectal cancer.